Last 12 months
Inside the activity.
0 purchase rows · 202 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 36 |
| Dec 2025 | 0 | 34 |
| Jan 2026 | 0 | 66 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 10 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 24 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2018 Filed Jun 13, 2018 00:50 UTC |
BAY CITY CAPITAL LLCDirector · 10% owner
|
SaleCommon Stock | 5,908 | $287.46 | $1,698,313.68 |
DisclosureSEC source: 0001179110-18-008424 · edgar.xml · nonDerivative · entry 2 BAY CITY CAPITAL LLC · CIK 0001288452 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 113,472 F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F3 · ownership.nature: The securities are held by Co-Investment IV. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 00:50 UTC |
BAY CITY CAPITAL LLCDirector · 10% owner
|
SaleCommon Stock | 274,092 | $287.46 | $78,790,486.32 |
DisclosureSEC source: 0001179110-18-008424 · edgar.xml · nonDerivative · entry 1 BAY CITY CAPITAL LLC · CIK 0001288452 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 5,264,382 F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F2 · ownership.nature: The securities are held by Fund IV. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 19:53 UTC |
Schneebaum Marc RChief Financial Officer
|
Exercise / conversionStock Option · Derivative | 2,734 | $0.00 Strike: $61.60 | $0.00 |
DisclosureSEC source: 0001179110-18-008437 · edgar.xml · derivative · entry 5 Schneebaum Marc R · CIK 0001396871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,640 Underlying: Common Stock · 2,734 shares Expires 2025-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 19:53 UTC |
Schneebaum Marc RChief Financial Officer
|
Exercise / conversionStock Option · Derivative | 5,223 | $0.00 Strike: $99.75 | $0.00 |
DisclosureSEC source: 0001179110-18-008437 · edgar.xml · derivative · entry 4 Schneebaum Marc R · CIK 0001396871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,205 Underlying: Common Stock · 5,223 shares Expires 2024-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 19:53 UTC |
Schneebaum Marc RChief Financial Officer
|
SaleCommon Stock | 10,099 | $287.46 | $2,903,058.54 |
DisclosureSEC source: 0001179110-18-008437 · edgar.xml · nonDerivative · entry 3 Schneebaum Marc R · CIK 0001396871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,668 Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 19:53 UTC |
Schneebaum Marc RChief Financial Officer
|
Exercise / conversionCommon Stock | 2,734 | $61.60 | $168,414.40 |
DisclosureSEC source: 0001179110-18-008437 · edgar.xml · nonDerivative · entry 2 Schneebaum Marc R · CIK 0001396871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 19:53 UTC |
Schneebaum Marc RChief Financial Officer
|
Exercise / conversionCommon Stock | 5,223 | $99.75 | $520,994.25 |
DisclosureSEC source: 0001179110-18-008437 · edgar.xml · nonDerivative · entry 1 Schneebaum Marc R · CIK 0001396871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Dec 13, 2019 13:41 UTC Amendment |
CRAVES FRED BDirector · 10% owner
|
SaleCommon Stock | 5,908 | $287.46 | $1,698,313.68 |
DisclosureSEC source: 0000899243-19-029126 · doc4a.xml · nonDerivative · entry 1 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 113,472 F1 · acquired: On June 12, 2018, the reporting person filed a Form 4 which inadvertently reported a transaction as an acquisition of common stock by including the "A" notation in Box 4 of Table I. In fact, as reported in this amendment, the transaction should have been reported with a "D" in Box 4 of Table I because the transaction in question was a disposition of common stock. F2 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. F3 · ownership.nature: These securities are held by Co-Investment IV. Dr. Craves disclaims beneficial ownership of these securities held by Co-Investment IV, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:47 UTC |
Schneebaum Marc RChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $124.45 | $0.00 |
DisclosureSEC source: 0001179110-18-003407 · edgar.xml · derivative · entry 1 Schneebaum Marc R · CIK 0001396871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2028-03-01 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (March 1, 2019) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues to serve as an officer of the Issuer on each such date. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:47 UTC |
Taub RebeccaDirector · Chief Medical Officer, EVP R&D · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 38,000 | $0.00 Strike: $124.45 | $0.00 |
DisclosureSEC source: 0001179110-18-003406 · edgar.xml · derivative · entry 1 Taub Rebecca · CIK 0001423898 · Director · Chief Medical Officer, EVP R&D · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2028-03-01 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (March 1, 2019) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues to serve as an officer of the Issuer on each such date. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:46 UTC |
FRIEDMAN PAUL ADirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $124.45 | $0.00 |
DisclosureSEC source: 0001179110-18-003405 · edgar.xml · derivative · entry 1 FRIEDMAN PAUL A · CIK 0001236927 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-03-01 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (March 1, 2019) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues to serve as an officer of the Issuer on each such date. Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 20:04 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 7 | $16.25 | $113.75 |
DisclosureSEC source: 0001179110-17-011806 · edgar.xml · nonDerivative · entry 4 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,100 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 20:04 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 1,793 | $16.12 | $28,903.16 |
DisclosureSEC source: 0001179110-17-011806 · edgar.xml · nonDerivative · entry 3 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,093 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 20:04 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 100 | $16.11 | $1,611.00 |
DisclosureSEC source: 0001179110-17-011806 · edgar.xml · nonDerivative · entry 2 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,300 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 20:04 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 100 | $16.08 | $1,608.00 |
DisclosureSEC source: 0001179110-17-011806 · edgar.xml · nonDerivative · entry 1 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 20:03 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 127 | $16.14 | $2,049.78 |
DisclosureSEC source: 0001179110-17-011766 · edgar.xml · nonDerivative · entry 4 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,100 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 20:03 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 2,944 | $16.12 | $47,457.28 |
DisclosureSEC source: 0001179110-17-011766 · edgar.xml · nonDerivative · entry 3 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,973 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 20:03 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 389 | $16.10 | $6,262.90 |
DisclosureSEC source: 0001179110-17-011766 · edgar.xml · nonDerivative · entry 2 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,029 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 20:03 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 90 | $15.99 | $1,439.10 |
DisclosureSEC source: 0001179110-17-011766 · edgar.xml · nonDerivative · entry 1 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,640 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 590 | $16.09 | $9,493.10 |
DisclosureSEC source: 0001179110-17-011725 · edgar.xml · nonDerivative · entry 12 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,550 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 440 | $16.07 | $7,070.80 |
DisclosureSEC source: 0001179110-17-011725 · edgar.xml · nonDerivative · entry 11 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,960 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 210 | $16.04 | $3,368.40 |
DisclosureSEC source: 0001179110-17-011725 · edgar.xml · nonDerivative · entry 10 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,520 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 200 | $16.02 | $3,204.00 |
DisclosureSEC source: 0001179110-17-011725 · edgar.xml · nonDerivative · entry 9 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,310 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 200 | $15.93 | $3,186.00 |
DisclosureSEC source: 0001179110-17-011725 · edgar.xml · nonDerivative · entry 8 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,110 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 10 | $15.90 | $159.00 |
DisclosureSEC source: 0001179110-17-011725 · edgar.xml · nonDerivative · entry 7 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,910 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 400 | $15.80 | $6,320.00 |
DisclosureSEC source: 0001179110-17-011725 · edgar.xml · nonDerivative · entry 6 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 200 | $15.79 | $3,158.00 |
DisclosureSEC source: 0001179110-17-011725 · edgar.xml · nonDerivative · entry 5 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 200 | $15.77 | $3,154.00 |
DisclosureSEC source: 0001179110-17-011725 · edgar.xml · nonDerivative · entry 4 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 100 | $15.72 | $1,572.00 |
DisclosureSEC source: 0001179110-17-011725 · edgar.xml · nonDerivative · entry 3 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 100 | $15.70 | $1,570.00 |
DisclosureSEC source: 0001179110-17-011725 · edgar.xml · nonDerivative · entry 2 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Levy Richard SDirector
|
PurchaseCommon Stock | 900 | $15.67 | $14,103.00 |
DisclosureSEC source: 0001179110-17-011725 · edgar.xml · nonDerivative · entry 1 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 18:00 UTC |
CRAVES FRED BDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.46 | $0.00 |
DisclosureSEC source: 0001179110-17-009843 · edgar.xml · derivative · entry 1 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-06-29 F1 · derivative.exercise_date: The option vests 100% on the first anniversary of the date of grant, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 22:01 UTC |
MILLIGAN DAVID VDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.46 | $0.00 |
DisclosureSEC source: 0001179110-17-009846 · edgar.xml · derivative · entry 1 MILLIGAN DAVID V · CIK 0001222252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-06-29 F1 · derivative.exercise_date: The option vests 100% on the first anniversary of the date of grant, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 22:01 UTC |
Levy Richard SDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.46 | $0.00 |
DisclosureSEC source: 0001179110-17-009845 · edgar.xml · derivative · entry 1 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-06-29 F1 · derivative.exercise_date: The option vests 100% on the first anniversary of the date of grant, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 22:00 UTC |
Gollust Keith RDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.46 | $0.00 |
DisclosureSEC source: 0001179110-17-009844 · edgar.xml · derivative · entry 1 Gollust Keith R · CIK 0001325712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-06-29 F1 · derivative.exercise_date: The option vests 100% on the first anniversary of the date of grant, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 21:59 UTC |
BATE KENNETHDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.46 | $0.00 |
DisclosureSEC source: 0001179110-17-009842 · edgar.xml · derivative · entry 1 BATE KENNETH · CIK 0001210238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-06-29 F1 · derivative.exercise_date: The option vests 100% on the first anniversary of the date of grant, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 20:19 UTC |
Taub RebeccaDirector · Chief Medical Officer, EVP R&D · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 37,300 | $0.00 Strike: $15.80 | $0.00 |
DisclosureSEC source: 0001179110-17-003951 · edgar.xml · derivative · entry 1 Taub Rebecca · CIK 0001423898 · Director · Chief Medical Officer, EVP R&D · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,300 Underlying: Common Stock · 37,300 shares Expires 2027-03-02 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (March 2, 2018) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues to serve as an officer of the Issuer on each such date. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 20:18 UTC |
Schneebaum Marc RChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 27,300 | $0.00 Strike: $15.80 | $0.00 |
DisclosureSEC source: 0001179110-17-003950 · edgar.xml · derivative · entry 1 Schneebaum Marc R · CIK 0001396871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,300 Underlying: Common Stock · 27,300 shares Expires 2027-03-02 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (March 2, 2018) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues to serve as an officer of the Issuer on each such date. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 20:18 UTC |
FRIEDMAN PAUL ADirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 49,600 | $0.00 Strike: $15.80 | $0.00 |
DisclosureSEC source: 0001179110-17-003949 · edgar.xml · derivative · entry 1 FRIEDMAN PAUL A · CIK 0001236927 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,600 Underlying: Common Stock · 49,600 shares Expires 2027-03-02 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (March 2, 2018) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues to serve as an officer of the Issuer on each such date. Read SEC document |
| August 11, 2016 Filed Nov 21, 2016 21:40 UTC |
Levy Richard SDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.36 | $0.00 |
DisclosureSEC source: 0001179110-16-031900 · edgar.xml · derivative · entry 1 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-08-11 F1 · derivative.exercise_date: Fifty percent (50%) of the option vests on August 11, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) successive quarters. The filing is late due to an administrative oversight. Read SEC document |
| July 22, 2016 Filed Oct 24, 2016 23:08 UTC |
MILLIGAN DAVID VDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $12.01 | $0.00 |
DisclosureSEC source: 0001179110-16-030884 · edgar.xml · derivative · entry 1 MILLIGAN DAVID V · CIK 0001222252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-07-22 F1 · derivative.exercise_date: Fifty percent (50%) of the option vests on July 22, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) successive quarters. The filing is late due to an administrative oversight. Read SEC document |
| July 22, 2016 Filed Oct 24, 2016 19:14 UTC |
CRAVES FRED BDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $12.01 | $0.00 |
DisclosureSEC source: 0001179110-16-030887 · edgar.xml · derivative · entry 1 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-07-22 F1 · derivative.exercise_date: Fifty percent (50%) of the option vests on July 22, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) successive quarters. The filing is late due to an administrative oversight. Read SEC document |
| July 22, 2016 Filed Oct 24, 2016 23:11 UTC |
Gollust Keith RDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $12.01 | $0.00 |
DisclosureSEC source: 0001179110-16-030886 · edgar.xml · derivative · entry 1 Gollust Keith R · CIK 0001325712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-07-22 F1 · derivative.exercise_date: Fifty percent (50%) of the option vests on July 22, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) successive quarters. The filing is late due to an administrative oversight. Read SEC document |
| July 22, 2016 Filed Oct 24, 2016 23:09 UTC |
BATE KENNETHDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $12.01 | $0.00 |
DisclosureSEC source: 0001179110-16-030885 · edgar.xml · derivative · entry 1 BATE KENNETH · CIK 0001210238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-07-22 F1 · derivative.exercise_date: Fifty percent (50%) of the option vests on July 22, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) successive quarters. The filing is late due to an administrative oversight. Read SEC document |
| July 22, 2016 Filed Nov 4, 2016 17:17 UTC Amendment |
CRAVES FRED BDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.45 | $0.00 |
DisclosureSEC source: 0001179110-16-031250 · edgar.xml · derivative · entry 1 CRAVES FRED B · CIK 0001014095 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-07-22 F1 · derivative.exercise_price: This report amends the original report to reflect the correct exercise price of $9.45 per share. F2 · derivative.exercise_date: Fifty percent (50%) of the option vests on July 22, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) successive quarters. Read SEC document |
| July 22, 2016 Filed Nov 4, 2016 21:16 UTC Amendment |
BATE KENNETHDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.45 | $0.00 |
DisclosureSEC source: 0001179110-16-031249 · edgar.xml · derivative · entry 1 BATE KENNETH · CIK 0001210238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-07-22 F1 · derivative.exercise_price: This report amends the original report to reflect the correct exercise price of $9.45 per share. F2 · derivative.exercise_date: Fifty percent (50%) of the option vests on July 22, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) successive quarters. Read SEC document |
| July 22, 2016 Filed Nov 4, 2016 21:17 UTC Amendment |
MILLIGAN DAVID VDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.45 | $0.00 |
DisclosureSEC source: 0001179110-16-031251 · edgar.xml · derivative · entry 1 MILLIGAN DAVID V · CIK 0001222252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-07-22 F1 · derivative.exercise_price: This report amends the original report to reflect the correct exercise price of $9.45 per share. F2 · derivative.exercise_date: Fifty percent (50%) of the option vests on July 22, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) consecutive quarters. Read SEC document |
| July 22, 2016 Filed Nov 4, 2016 21:16 UTC Amendment |
Gollust Keith RDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.45 | $0.00 |
DisclosureSEC source: 0001179110-16-031248 · edgar.xml · derivative · entry 1 Gollust Keith R · CIK 0001325712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-07-22 F1 · derivative.exercise_price: This report amends the original report to reflect the correct exercise price of $9.45 per share. F2 · derivative.exercise_date: Fifty percent (50%) of the option vests on July 22, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) successive quarters. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.